Skip to main content
Top
Published in: BMC Urology 1/2020

Open Access 01-12-2020 | Nephrostomy | Case report

532 nm green-light laser vaporization of upper tract urothelial carcinoma

Authors: F. Dursun, M. M. Pan, M. Morgan, R. R. Gonzalez, R. Satkunasivam

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

Endoscopic management of low risk upper tract urothelial carcinoma (UTUC) may be considered in select clinical scenarios, which allows sparing the morbidity of radical nephroureterectomy while achieving acceptable oncological outcomes and preservation of kidney function. Herein, we present a case with UTUC in a solitary kidney managed with 532 nm laser vaporization through a percutaneous approach.

Case presentation

The patient in this video (Additional file 1) is an 85-year-old woman who presented with a bulky tumor in the collecting system of a congenital solitary left kidney, which was a biopsy proven low grade urothelial carcinoma. Prior to the procedure, a lower pole percutaneous nephrostomy tube was successfully placed under sedation by Interventional Radiology. The procedure was done in a prone split leg position. The mass, which was predominantly localized to the renal pelvis was efficiently vaporized with the 532 nm laser in a systematic manner with continuous irrigation of normal saline through the cystoscope. The patient was discharged home on postoperative day 2 with the nephroureterostomy catheter open to drainage. This catheter was subsequently clamped and removed two weeks later without complications. Follow up uretroscopy showed excellent treatment response and the patient remains well without complications.

Conclusion

This case report details the potential utility of 532 nm laser vaporization of UTUC, however, ongoing studies are required to demonstrate peri-operative safety and durable oncologic efficacy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CACancer J Clin. 2017;67:7–30. CrossRef Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CACancer J Clin. 2017;67:7–30. CrossRef
2.
go back to reference Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29:481–6. CrossRefPubMed Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29:481–6. CrossRefPubMed
3.
go back to reference Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical neph-roureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33. CrossRefPubMed Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical neph-roureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33. CrossRefPubMed
4.
go back to reference Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcomes of kidney-sparing surgery versus radical nephroureterecomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol. 2016;70:1052–68. CrossRefPubMed Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcomes of kidney-sparing surgery versus radical nephroureterecomy for upper tract urothelial carcinoma: a systematic review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol. 2016;70:1052–68. CrossRefPubMed
5.
go back to reference Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69:94–102. CrossRefPubMed Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69:94–102. CrossRefPubMed
6.
go back to reference He D, Fan J, Wu K, et al. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience. J Endourol. 2014;28(8):975–9. CrossRefPubMed He D, Fan J, Wu K, et al. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience. J Endourol. 2014;28(8):975–9. CrossRefPubMed
8.
go back to reference Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol. 2018;273:111–22. CrossRef Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Eur Urol. 2018;273:111–22. CrossRef
9.
go back to reference Dołowy Ł, Krajewski W, Dembowski J, et al. The role of lasers in modern urology. Cent Eur J Urol. 2015;68:175–82. CrossRef Dołowy Ł, Krajewski W, Dembowski J, et al. The role of lasers in modern urology. Cent Eur J Urol. 2015;68:175–82. CrossRef
Metadata
Title
532 nm green-light laser vaporization of upper tract urothelial carcinoma
Authors
F. Dursun
M. M. Pan
M. Morgan
R. R. Gonzalez
R. Satkunasivam
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00744-w

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue